Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Design Therapeutics (DSGN)
NASDAQ:DSGN
Design Therapeutics (DSGN) Ownership - Who Owns Design Therapeutics?
68 Followers
Design Therapeutics (DSGN) Ownership Overview
57.68% Insiders
8.09% Mutual Funds
6.98% Other Institutional Investors
27.24% Public Companies and
Individual Investors
The ownership structure of Design Therapeutics (DSGN) stock is a mix of institutional, retail and individual investors. Approximately 15.08% of the company’s stock is owned by Institutional Investors, 57.68% is owned by Insiders and 27.24% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Mar 25, 2024 | John Schmid Director | Bought | $99659 |
| Mar 25, 2024 | Heather A. Berger Director | Bought | $4862 |
| Oct 02, 2023 | Rodney Lappe Director | Bought | $49140 |
| Aug 30, 2023 | Deepa Prasad Director | Bought | $27600 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2023 | Bought | $59807 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,971,231 | Institution | 5.26% | 10,874,705 | |
| 1,500,000 | Institution | 2.66% | 5,490,000 | |
| 1,248,368 | Institution | 2.21% | 4,569,027 | |
| 1,160,604 | Institution | 2.05% | 4,247,811 | |
| 1,097,434 | Institution | 1.94% | 4,016,608 | |
| 957,005 | Institution | 1.69% | 3,502,638 | |
| 390,858 | Institution | 0.69% | 1,430,540 | |
| 342,813 | Institution | 0.61% | 1,254,696 | |
| 258,349 | Institution | 0.46% | 945,557 | |
| 254,737 | Institution | 0.45% | 932,337 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,097,434 | Institution | 1.94% | 4,016,608 | |
| 957,005 | Institution | 1.69% | 3,502,638 | |
| 390,858 | Institution | 0.69% | 1,430,540 | |
| 342,813 | Institution | 0.61% | 1,254,696 | |
| 258,349 | Institution | 0.46% | 945,557 | |
| 254,737 | Institution | 0.45% | 932,337 | |
| 215,100 | Institution | 0.38% | 787,266 | |
| 193,867 | Institution | 0.34% | 709,553 | |
| 137,719 | Institution | 0.24% | 504,052 | |
| 131,946 | Institution | 0.23% | 482,922 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 779,108 | Institution | 1.38% | 2,851,535 | |
| 703,901 | Institution | 1.25% | 2,836,721 | |
| 399,505 | Institution | 0.71% | 1,610,005 | |
| 301,715 | Institution | 0.53% | 1,104,277 | |
| 121,421 | Institution | 0.21% | 489,327 | |
| 104,720 | Institution | 0.19% | 383,275 | |
| 70,887 | Institution | 0.13% | 259,446 | |
| 46,827 | Institution | 0.08% | 173,260 | |
| 54,007 | Institution | 0.10% | 150,139 | |
| 21,210 | Institution | 0.04% | 85,476 |
FAQ
Who Owns Design Therapeutics (DSGN)?
According to the latest TipRanks data, approximately 6.98% of the company's stock is held by institutional investors, 57.68% is held by insiders, and 27.24% is held by retail investors.
What percentage of Design Therapeutics (DSGN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 6.98% of Design Therapeutics (DSGN) stock is held by institutional investors.
What percentage of Design Therapeutics (DSGN) stock is held by retail investors?
According to the latest TipRanks data, approximately 27.24% of Design Therapeutics (DSGN) stock is held by retail investors.
Who owns the most shares of Design Therapeutics (DSGN)?
Peter Kolchinsky owns the most shares of Design Therapeutics (DSGN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.